VOWELEN Trademark

Trademark Overview

On Tuesday, June 17, 2014, a trademark application was filed for VOWELEN with the United States Patent and Trademark Office. The USPTO has given the VOWELEN trademark a serial number of 86312116. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, January 10, 2025. This trademark is owned by Glaxo Group Limited. The VOWELEN trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines
vowelen

General Information

Serial Number86312116
Word MarkVOWELEN
Filing DateTuesday, June 17, 2014
Status710 - CANCELLED - SECTION 8
Status DateFriday, January 10, 2025
Registration Number5500116
Registration DateTuesday, June 26, 2018
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 28, 2014

Trademark Statements

Goods and ServicesPharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, January 10, 2025
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGlaxo Group Limited
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS
GB
Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS
Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS

Trademark Events

Event DateEvent Description
Friday, June 20, 2014NEW APPLICATION ENTERED
Wednesday, June 25, 2014NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, September 24, 2014ASSIGNED TO EXAMINER
Thursday, September 25, 2014APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, October 8, 2014NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, October 28, 2014PUBLISHED FOR OPPOSITION
Tuesday, October 28, 2014OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 23, 2014NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, June 1, 2015SOU TEAS EXTENSION RECEIVED
Monday, June 1, 2015SOU EXTENSION 1 FILED
Monday, June 1, 2015SOU EXTENSION 1 GRANTED
Wednesday, June 3, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, June 23, 2015TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, November 18, 2015SOU TEAS EXTENSION RECEIVED
Wednesday, November 18, 2015SOU EXTENSION 2 FILED
Friday, December 11, 2015CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, December 15, 2015SOU EXTENSION 2 GRANTED
Wednesday, December 16, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, May 31, 2016SOU TEAS EXTENSION RECEIVED
Tuesday, May 31, 2016SOU EXTENSION 3 FILED
Friday, June 10, 2016SOU EXTENSION 3 GRANTED
Saturday, June 11, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, December 6, 2016SOU TEAS EXTENSION RECEIVED
Tuesday, December 6, 2016SOU EXTENSION 4 FILED
Saturday, January 7, 2017SOU EXTENSION 4 GRANTED
Tuesday, January 10, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, June 15, 2017NOTICE OF ALLOWANCE CANCELLED
Thursday, June 15, 2017TEAS POST PUBLICATION AMENDMENT RECEIVED
Friday, August 11, 2017CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, September 20, 20171(B) BASIS DELETED; PROCEED TO REGISTRATION
Friday, September 22, 2017ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
Monday, April 16, 2018TEAS POST PUBLICATION AMENDMENT RECEIVED
Wednesday, May 2, 2018ASSIGNED TO PETITION STAFF
Wednesday, May 2, 2018CHANGES/CORRECTIONS AFTER PUB APPROVAL ENTERED
Tuesday, May 22, 2018ELECTRONIC RECORD REVIEW COMPLETE
Tuesday, June 26, 2018REGISTERED-PRINCIPAL REGISTER
Monday, December 9, 2019ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, December 9, 2019TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, November 9, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, November 9, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, November 9, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, November 9, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, November 9, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, June 26, 2023COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Friday, January 10, 2025CANCELLED SEC. 8 (6-YR)

Related Keywords

vowelen pharmaceutical treatment disorders preparations substances diseases ophthalmic respiratory hepatological oncological